Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126194361 | 12619436 | 1 | I | 20160720 | 20160803 | 20160803 | EXP | US-UNICHEM LABORATORIES LIMITED-UCM201607-000165 | UNICHEM | CHALASANI N,BONKOVSKY H,FONTANA R,LEE W,STOLZ A,TALWALKAR J. FEATURES AND OUTCOMES OF 899 PATIENTS WITH DRUG-INDUCED LIVER INJURY: THE DILIN PROSPECTIVE STUDY. GASTROENTEROLOGY 2015 JUN;148(7):1-27. | 48.00 | YR | F | Y | 0.00000 | 20160803 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126194361 | 12619436 | 1 | PS | LAMOTRIGINE. | LAMOTRIGINE | 1 | 90170 | ||||||||||||
126194361 | 12619436 | 2 | SS | CEPHALEXIN. | CEPHALEXIN | 1 | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126194361 | 12619436 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126194361 | 12619436 | Drug-induced liver injury | |
126194361 | 12619436 | Toxic epidermal necrolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |